Abstract
Ketamine has several properties that make it an ideal sedative such as potent analgesia, minimal cardiovascular (CV) side effects, lack of respiratory depression and newly discovered antidepressant actions. The purpose of this study was to describe the use of CI ketamine in patients receiving concurrent IV analgesia/sedation while on ECMO. The aim of this study was to determine if an improvement in RASS scores occurred after the initiation of ketamine or if a dose reduction in concurrent IV analgesics/sedatives occurred.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
